Antifungal Ingredients: Terbinafine, Clotrimazole, Miconazole & Tolnaftate

The fastest way to compare an antifungal shelf

Ignore the front-of-box brand hierarchy for a moment and find four things:

Active ingredient
Concentration
Body site / infection on the label
Course length and application directions

Those details are more useful than assuming a famous brand is stronger or that every product saying “antifungal” treats the same infection.

Common OTC skin antifungals

Active ingredient	Class	Common labeled skin uses	Important boundary
Terbinafine	Allylamine	Athlete’s foot, ringworm, jock itch on appropriate products	OTC skin cream does not adequately treat nail fungus
Clotrimazole	Azole	Athlete’s foot, ringworm, jock itch; separate vaginal formulations also exist	Skin and vaginal formulations are not interchangeable
Miconazole	Azole	Dermatophyte skin infections; separate vaginal formulations exist	Check formulation and body-site labeling
Tolnaftate	Thiocarbamate	Athlete’s foot, ringworm and jock itch on labeled products	Not a general treatment for Candida infections

Why nail fungus needs its own category

Toenail fungus is not simply “athlete’s foot under the nail.” The nail plate creates a penetration problem. AAD specifically notes that nonprescription terbinafine cream treats fungal skin infections but cannot adequately penetrate the nail to treat onychomycosis.

Prescription nail-directed medicines include efinaconazole, tavaborole and ciclopirox, while oral antifungals such as terbinafine or itraconazole are separate clinician-managed options.

See nail fungus.

Why vaginal yeast products need their own category

CDC guidelines list intravaginal formulations of clotrimazole, miconazole and tioconazole for uncomplicated vulvovaginal candidiasis. Their concentrations, delivery systems and courses are designed for vaginal use. A skin cream carrying the same molecule name should not be assumed equivalent.

See vaginal yeast infection.

Oral thrush is another formulation problem

Mouth and throat candidiasis uses medicines formulated and dosed for oral use, including clotrimazole, miconazole or nystatin for many mild-to-moderate cases and systemic therapy when appropriate. Do not place ordinary skin or vaginal antifungal products in the mouth.

See oral thrush.

What an antifungal product comparison should capture

A useful product record should show:

active ingredient and concentration;
dosage form (cream, spray, powder, solution, lacquer, suppository, oral formulation);
labeled indication;
labeled body site;
application frequency;
labeled course length;
age limits where stated;
major label warnings;
whether the product is OTC or prescription;
primary label or prescribing-information source.

Those fields keep diagnosis, body site and formulation attached to the comparison instead of reducing different antifungal products to a single strength ranking.

Primary references

CDC, Ringworm: https://www.cdc.gov/ringworm/
CDC STI Treatment Guidelines, Vulvovaginal Candidiasis: https://www.cdc.gov/std/treatment-guidelines/candidiasis.htm
American Academy of Dermatology, Nail fungus diagnosis and treatment: https://www.aad.org/public/diseases/a-z/nail-fungus-treatment